These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 7827146)
61. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma. Carella AM; Cavaliere M; Lerma E; Ferrara R; Tedeschi L; Romanelli A; Vinci M; Pinotti G; Lambelet P; Loni C; Verdiani S; De Stefano F; Valbonesi M; Corsetti MT J Clin Oncol; 2000 Dec; 18(23):3918-24. PubMed ID: 11099321 [TBL] [Abstract][Full Text] [Related]
62. Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma? Specht L Curr Treat Options Oncol; 2016 Jan; 17(1):4. PubMed ID: 26739151 [TBL] [Abstract][Full Text] [Related]
63. [Treatment of aggressive non-Hodgkin's lymphoma in aged patients with a combination of methyl-GAG, etoposide and prednimustine]. Solal-Celigny P; Tertian G; Herrera A; Brousse N; Peuchmaur M Bull Cancer; 1990; 77(5):449-52. PubMed ID: 2400814 [TBL] [Abstract][Full Text] [Related]
64. High dose chemotherapy and autologous stem cell transplantation for poor risk and recurrent non-Hodgkin's lymphoma: a single-center experience of 50 patients. Shim BY; Lee MA; Byun JH; Roh SY; Song CW; Park JN; Lee JW; Min WS; Hong YS; Kim CC Korean J Intern Med; 2004 Jun; 19(2):114-20. PubMed ID: 15366643 [TBL] [Abstract][Full Text] [Related]
65. Recent advances in the management of non-Hodgkin's lymphomas. Gaynor ER; Fisher RI Dis Mon; 1989 Sep; 35(9):597-650. PubMed ID: 2676434 [TBL] [Abstract][Full Text] [Related]
66. Therapy for childhood non-Hodgkin's lymphomas, nonlymphoblastic type. Review of recent studies and current recommendations. Nachman J Am J Pediatr Hematol Oncol; 1990; 12(3):359-66. PubMed ID: 2240485 [TBL] [Abstract][Full Text] [Related]
67. European School of Oncology: management of non-Hodgkin's lymphomas: conclusions of the European School of Oncology Meeting, 1986. Coiffier B; Bosly A; Caligaris-Cappio F; Gisselbrecht C; Patte C; Schaadt M; Symann M Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1691-5. PubMed ID: 3322847 [No Abstract] [Full Text] [Related]
68. [Hypothermia during chemotherapy for lymphomas]. Gabryś K; Mazur G Pol Arch Med Wewn; 1995 Feb; 93(2):130-4. PubMed ID: 7479230 [TBL] [Abstract][Full Text] [Related]
69. [Non-Hodgkin lymphoma in the elderly]. Dupuis J; Haioun C Bull Cancer; 2008 May; 95 FMC Onco():F79-83. PubMed ID: 18511372 [TBL] [Abstract][Full Text] [Related]
70. Preparation for marrow transplantation in Hodgkin's and non-Hodgkin's lymphoma using Bu/CY. Avalos BR; Klein JL; Kapoor N; Tutschka PJ; Klein JP; Copelan EA Bone Marrow Transplant; 1993 Aug; 12(2):133-8. PubMed ID: 8401359 [TBL] [Abstract][Full Text] [Related]
72. Cytarabine, cisplatin, and etoposide chemotherapy for refractory non-Hodgkin's lymphoma. O'Donnell MR; Forman SJ; Levine AM; Territo M; Farbstein MJ; Fahey JL; Gill P; Lazar G; Nademanee A; Neely S Cancer Treat Rep; 1987 Feb; 71(2):187-9. PubMed ID: 3802114 [TBL] [Abstract][Full Text] [Related]
73. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL). Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814 [TBL] [Abstract][Full Text] [Related]
74. A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group. Santini G; De Souza C; Aversa S; Patti C; Tedeschi L; Candela M; Olivieri A; Chisesi T; Rubagotti A; Centurioni R; Nardi V; Congiu M; Gennaro M; Truini M; Braz J Med Biol Res; 2004 May; 37(5):719-28. PubMed ID: 15107935 [TBL] [Abstract][Full Text] [Related]
75. [Ocular manifestations in non-Hodgkin's lymphomas]. Glavici M; Comănescu V; Glavici A Oftalmologia; 1994; 38(3):242-6. PubMed ID: 7520276 [TBL] [Abstract][Full Text] [Related]
76. Relapse with nodular lymphoma following combination chemotherapy for diffuse non-Hodgkin's lymphoma. Siegel RD; Skarin AT; Canellos GP Am J Clin Oncol; 1986 Oct; 9(5):420-3. PubMed ID: 2430447 [TBL] [Abstract][Full Text] [Related]
77. [Non-Hodgkin's lymphoma: a new less toxic treatment doubles the prognosis]. Sabourin G Perspect Infirm; 2012; 9(6):60. PubMed ID: 23234232 [No Abstract] [Full Text] [Related]
79. [Dose reduction is not recommended for elderly patients undergoing chemotherapy for non-Hodgkin lymphoma]. Sonneveld P; Huijgens PC; Hagenbeek A Ned Tijdschr Geneeskd; 1999 Feb; 143(8):418-9. PubMed ID: 10221113 [TBL] [Abstract][Full Text] [Related]
80. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma. Spina M; Simonelli C; Tirelli U J Clin Oncol; 2007 Feb; 25(6):e7. PubMed ID: 17308261 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]